A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 78, Issue 1, 2007, Pages 132-135

  Pala, L ^a   Mannucci, E ^a   Dicembrini, I ^a   Rotella, C M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Insulin aspart; Metformin; Oral hypoglycemic agents; Postprandial hyperglycemia; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPOGLYCEMIA; LIPID BLOOD LEVEL; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EATING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED;

EID: 34548329984     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.02.010     Document Type: Article

References (22)

1. Chow C.C., Tsang L.W., Sorensen J.P., and Cockram C.S. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diab. Care 18 3 (1995) 307-314
2. Clauson P., Karlander S., Steen L., and Efendic S. Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up. Diabet. Med. 13 5 (1996) 471-477
3. Ponssen H.H., Elte J.W., Lehert P., Schouten J.P., and Bets D. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus. Clin. Ther. 22 6 (2000) 709-718
4. Yki-Jarvinen H., Ryysy L., Nikkila K., Tulokas T., Vanamo R., and Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus.A randomized, controlled trial. Ann. Int. Med. 130 5 (1999) 389-396
5. Giugliano D., Quatraro A., Consoli G., Minei A., Ceriello A., De Rosa N., et al. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur. J. Pharmacol. 44 2 (1993) 107-112
6. Robinson A.C., Burke J., Robinson S., Johnston D.G., and Elkeles R.S. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diab. Care 21 5 (1995) 701-705
7. Relimpio F., Pumar A., Losada F., Mangas M.A., Acosta D., and Astorga R. Adding metformin versus insulin dose increase in insulin-treated but poorly controlled type 2 diabetes mellitus: an open-label randomized trial. Diabet. Med. 15 12 (1998) 997-1002
8. Aviles-Santa L., Sinding J., and Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 131 3 (1999) 182-188
9. The DECODE study group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe, Lancet 354 (1999) 617-621
10. American Diabetes Association. Standards of Medical Care in Diabetes-2006. Diab. Care 29 (2006) S4-S42
11. Bastyr III E.J., Johnson M.E., Trautmann M.E., Anderson Jr. J.H., and Vignati L. Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure. Clin. Ther. Oct. 21 10 (1999) 1703-1714
12. Raskin P., Guthrie R.A., Leiter L., Riis A., and Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diab. Care 23 May (5) (2000) 583-588
13. Riis European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabet. Med. 17 11 (2000) 762-770
14. Insulin Aspart Study Group. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diab. Res. Clin. Prat. 54 2 (2001) 105-114
15. The TriContinental Insulin Aspart Study Group. A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with type 1 diabetes. Diabet. Med. 20 4 (2003) 312-318
16. Perriello G., Pampanelli S., Porcellati F., Avogaro A., Bosi E., Petrella G., et al. Insulin aspart improves meal time glycaemic control in patients with type 2 diabetes: a randomized, stratified, double-blind and cross-over trial. Diabet. Med. 22 May (5) (2005) 606-611
17. Rosenfalck A.M., Thorsby P., Kjems L., Birkeland K., Dejgaard A., Hanssen K.F., et al. Improved postprandial glycaemic control with insulin aspart in type 2 diabetic patients treated with insulin. Acta Diabetol. 37 March (1) (2000) 41-46
18. Tai M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diab. Care 17 (1994) 152-154
19. Polonsky K.S., Given B.D., Hirsch L.J., Tillil H., Shapiro E.T., Beebe C., et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 318 May (19) (1988) 1231-1239
20. Poulsen M.K., Henriksen J.E., Hother-Nielsen O., and Beck-Nielsen H. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients. Diab. Care 26 December (12) (2003) 3273-3279
21. de Boer H., Keizers R., Jansen M., Verschoor L., and Ruineman-Koerts J. Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen. Diabetes Obes. Metab. 8 5 (2006) 517-523
22. Kokic S., Bukovic D., Radman M., Capkun V., Gabric N., Lesko V., et al. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure. Coll. Antropol. 27 1 (2003) 181-187